✦ LIBER ✦

Diagnosis and treatment of epstein-barr virus-associated natural killer cell lymphoproliferative disease

✍ Scribed by Keisei Kawa

Book ID: 105675724
Publisher: Carden Jennings Publishing
Year: 2003
Tongue: English
Weight: 134 KB
Volume: 78
Category: Article
ISSN: 0925-5710
DOI: 10.1007/bf02983236

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Allogeneic hematopoietic stem cell trans

Allogeneic hematopoietic stem cell transplantation for Epstein–Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan

✍ Emiko Sato; Shouichi Ohga; Hiroshi Kuroda; Fumiaki Yoshiba; Miki Nishimura; Masa 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 2 views

Aggressive natural killer cell lymphopro

Aggressive natural killer cell lymphoproliferative disorder associated with Epstein-Barr viral RNA

✍ Hirose, Yuko; Masaki, Yasufumi; Yoshioka, Ritsuko; Takiguchi, Tomoo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB 👁 2 views

Lymphoproliferative disorder of natural killer cells is a heterogeneous disorder, and an association with Epstein-Barr virus (EBV) is suggested in some cases. A Japanese male presenting with recurrent nasopharyngeal problems developed fever, generalized lymphadenopathy, and hepatosplenomegaly. Separ

Molecular markers of clonality and ident

Molecular markers of clonality and identity in epstein–barr virus-associated B-cell lymphoproliferative disease

✍ Dennis M. Walling; Leslie A. Andritsos; Wiguins Etienne; Deborah A. Payne; Judit 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

## Abstract Epstein–Barr virus (EBV)‐associated B‐cell lymphoproliferative disease may be polyclonal, oligoclonal, or monoclonal. The degree of tumor clonality reflects the disease pathogenesis and may have implications for disease diagnosis, prognosis, and treatment. In this study, specimens of EB

Epstein–Barr virus-associated B cell lym

Epstein–Barr virus-associated B cell lymphoproliferative disease after non-myeloablative allogeneic stem cell transplantation

✍ Milpied, N; Coste-Burel, M; Accard, F; Moreau, A; Moreau, P; Garand, R; Harousse 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 24 KB

Prolonged hypogammaglobulinemia followin

Prolonged hypogammaglobulinemia following rituximab treatment for post transplant Epstein–Barr virus-associated lymphoproliferative disease

✍ Imashuku, S; Teramura, T; Morimoto, A; Naya, M; Kuroda, H 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 104 KB

In vivo models for Epstein–Barr virus (E

In vivo models for Epstein–Barr virus (EBV)-associated B cell lymphoproliferative disease (BLPD)

✍ I. Johannessen; D. H. Crawford 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 2 views

EBV infects B lymphocytes in vivo and establishes a life-long persistent infection in the host. The latent infection is controlled by EBV-specific MHC class 1-restricted CTL. Immunosuppression reduces CTL activity, and this facilitates outgrowth of EBV+ve B cell lymphoproliferative disease (BLPD). B